vimarsana.com
Home
Live Updates
FDA Clears Cingulate to File for Marketing Approval of : vim
FDA Clears Cingulate to File for Marketing Approval of : vim
FDA Clears Cingulate to File for Marketing Approval of
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application
Advancing Discussions with Commercialization Partners...
Related Keywords
United States ,
Kansas ,
Kansas City ,
American ,
Shanej Schaffer ,
Matt Kreps ,
Thomas Dalton ,
Ann Childress ,
Darrow Associates ,
Exchange Commission ,
Nasdaq ,
Psych Congress First Annual Poster ,
Drug Administration ,
American Professional Society ,
Behavior Medicine Inc ,
Securities Exchange ,
Psych Congress ,
Platform Technology ,
Cingulate Inc ,
Date Sufficient ,
New Drug Application ,
Currently Using Immediate Release Booster ,
Precision Timed Release ,
Attention Deficit Hyperactivity Disorder ,
Cingulate Chairman ,
Behavior Medicine ,
Professional Society ,
Related Disorders ,
First Annual Poster ,
Hyperactivity Disorder ,
Erosion Barrier Layer ,
Looking Statements ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
Public Relations ,